Robotic Ivor Lewis esophagectomy shows major advantages for patients with esophageal cancer. Lower rates of recurrent laryngeal nerve palsy (87% reduction), reoperation (40% reduction), anastomotic leak (53% reduction), and respiratory complications (47% reduction). Gains in lymph node retrieval (8.3 nodes more) vs. transhiatal, despite longer operative time and more pulmonary complications. This data supports selecting […]

Minimally invasive techniques reduce complications in esophagectomy without affecting survival. Pulmonary complications are 53% lower with minimally invasive esophagectomy (MIE) and 61% lower with robot-assisted MIE compared to open esophagectomy. Robot-assisted MIE shows higher lymph node yield and lower reoperation rates than open approaches. Surgeons should consider MIE and robot-assisted techniques to enhance patient outcomes […]

A new expanded mediastinoscopic approach shows significant benefits over traditional methods in radical esophagectomy. The new technique (EMLE) cut operative time by 161 minutes (329.71 vs. 168.84 min) and halved blood loss (167.84 vs. 94.87 ml) compared to inflatable mediastinoscopic (IMLE) surgery. Postoperative complications dropped significantly with EMLE, including a reduced risk of recurrent laryngeal […]

Nutritional and inflammatory markers can significantly influence outcomes after esophagectomy for esophageal squamous cell carcinoma. Malnutrition and systemic inflammation adversely affect recovery and surgical results. Key markers include albumin, C-reactive protein, and the neutrophil-to-lymphocyte ratio, which guide patient risk assessments. Utilizing these markers can enhance preoperative planning and postoperative monitoring. Future approaches may incorporate novel […]

A new model accurately predicts 3-year mortality for patients with resected esophageal or gastroesophageal junction cancer, aiming to enhance surgical decision-making. Internally validated with 2,124 Ontario patients, it shows an AUC of 0.77, indicating good predictive power. Externally validated with 318 Manitoba patients, it maintains strong results, AUC of 0.73. This tool may improve patient […]

Minimally invasive esophagectomy (MIE) significantly improves survival for older esophageal cancer patients compared to open esophagectomy (OE). MIE offers a median overall survival of 60.17 months vs. 29.18 months for OE (HR=1.566, p=0.002). Disease-free survival is also better with MIE (37.70 months vs. 25.20 months, HR=1.411, p=0.010). MIE has similar major complication rates as OE, […]

Multicenter trials in esophagogastric cancer have not improved overall survival, raising urgent questions about trial design. 27 trials were analyzed; only 10 aimed for survival superiority, none achieved significant benefits. Common issues included limited surgeon credentialing and poor adherence monitoring. Trials often lacked adequate power and internal piloting, with a 10% nonadherence potentially halving statistical […]

Transcutaneous laryngeal ultrasound shows promise in detecting vocal cord paralysis after esophagectomy, crucial for surgical outcomes. Pooled sensitivity of 79% and specificity of 95% highlight its potential as a diagnostic tool. Vocal cord visualization achieved rates of 92.3%, with a 29% incidence of vocal cord paralysis post-surgery. Consider this tool for assessing high-risk patients, but […]